A blog founded by Teddy Zartler and run by Dan Erlanson for Fragment-based Drug Discovery devotees to discuss non-confidential issues regarding fragments.
Joined February 2019
- Tweets400
- Following13
- Followers1.2K
- Likes19
Strategies for covalency:
@VividionRx recognize covalent potential on inflammasome target NLRP3, scan proteome to find cryptic site, assess promiscuity, improve selectivity, and present a chemical probe in @BrJPharmacol
practicalfragments.blogspot.…
Free, virtual biophysics conference October 28! This has always been a fun event, so hope to see you online.
novalix-virtualconference.or…
youtube.com/watch?v=SpBCVTOB…
linkedin.com/posts/novalix_w…
@novalix_pharma @frankmoffatt